Currently out of the existing stock ratings of Karina Rabayeva, 1 are a BUY (100%).

Karina Rabayeva

Work Performance Price Targets & Ratings Chart

Analyst Karina Rabayeva, currently employed at TRUIST,

Karina Rabayeva’s has documented 2 price targets and ratings displayed on 1 stocks.

Most recent stock forecast was given on JANX, Janux Therapeutics at 10-Sep-2025.

Wall Street Analyst Karina Rabayeva

Analyst best performing recommendations are on JANX (JANUX THERAPEUTICS).
JANX Janux Therapeutics

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 05-Sep-2024

$55

$38.34 (230.13%)

$58

2 months 23 days ago
(07-Aug-2026)

0/7 (0%)

$39.15 (247.00%)

Buy Since 19-Aug-2025

$26

$11.06 (74.03%)

$30

5 months 22 days ago
(08-May-2026)

0/3 (0%)

$11.82 (83.36%)

Buy Since 06-Apr-2023

$36

$21.06 (140.96%)

$74

5 months 22 days ago
(08-May-2026)

5/8 (62.5%)

$21.82 (153.88%)

232

Buy Since 22-Nov-2024

$45

$28.34 (170.11%)

$89

6 months 2 days ago
(28-Apr-2026)

0/4 (0%)

$30.5 (210.34%)

Buy Since 17-Sep-2025

$14

$-2.66 (-15.97%)

$29

6 months 10 days ago
(20-Apr-2026)

1/4 (25%)

$-1.87 (-11.78%)

25

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by Karina Rabayeva?

On 2025
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?